PRKAA1 and neoplasm: However, doubt developed in the scientific community, as to whether metformin is able to mediate direct anti-tumor activity and activate AMPK in tumor cells, since many studies showed activity of the drug in cancer cell lines only at mM concentrations of metformin that cannot be achieved clinically [87, 119, 120].